5-chloro-2-[(3S)-1-[2-(difluoromethyl)-4-(2-propan-2-ylphenyl)phenyl]pyrrolidin-3-yl]sulfanylpyridine
C25H25ClF2N2S — CID 171559512
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-chloro-2-[(3S)-1-[2-(difluoromethyl)-4-(2-propan-2-ylphenyl)phenyl]pyrrolidin-3-yl]sulfanylpyridine
5-chloro-2-[(3S)-1-[2-(difluoromethyl)-4-(2-propan-2-ylphenyl)phenyl]pyrrolidin-3-yl]sulfanylpyridine (PubChem CID 171559512) has the molecular formula C25H25ClF2N2S and a molecular weight of 459.01 g/mol. Its IUPAC name is 5-chloro-2-[(3S)-1-[2-(difluoromethyl)-4-(2-propan-2-ylphenyl)phenyl]pyrrolidin-3-yl]sulfanylpyridine.
Molecular Properties
| Compound Name | 5-chloro-2-[(3S)-1-[2-(difluoromethyl)-4-(2-propan-2-ylphenyl)phenyl]pyrrolidin-3-yl]sulfanylpyridine |
|---|---|
| PubChem CID | 171559512 |
| Molecular Formula | C25H25ClF2N2S |
| Molecular Weight | 459.01 g/mol |
| Exact Mass | 458.14 |
| IUPAC Name | 5-chloro-2-[(3S)-1-[2-(difluoromethyl)-4-(2-propan-2-ylphenyl)phenyl]pyrrolidin-3-yl]sulfanylpyridine |
| SMILES | CC(C)c1ccccc1-c1ccc(N2CC[C@H](Sc3ccc(Cl)cn3)C2)c(C(F)F)c1 |
| InChI | InChI=1S/C25H25ClF2N2S/c1-16(2)20-5-3-4-6-21(20)17-7-9-23(22(13-17)25(27)28)30-12-11-19(15-30)31-24-10-8-18(26)14-29-24/h3-10,13-14,16,19,25H,11-12,15H2,1-2H3/t19-/m0/s1 |
| InChIKey | DACWJHHBDBGOCH-IBGZPJMESA-N |
| XLogP | 7.83 |
| TPSA | 16.13 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.01 |
| LogP ≤ 5 | 7.83 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171559512 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.